Mita E, Liu LJ, Shing D, Force L, et al. Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan. Intern Med 2023;62:1405-1414.
PMID: 36047126